Treatment of DR-TB with HIV Coinfection
- Read more about Treatment of DR-TB with HIV Coinfection
- Log in to post comments
treatment regimen /dose adjustments, special considerations and ADR management
treatment regimen /dose adjustments, special considerations and ADR management
Explain the opportunities to review TB-HIV collaborative activities at various forums, and levels.
Describe various indicators. See annexure 15 from NACP/NTEP framework
How captured? Source of information, who will feed data? who can view and what is the importance? Show the Nikshay interface.
Need, what to see, why and so what? Way forward
Need, what to see, why and so what? Way forward. Include checklists for NAAT, CDST Labs
Need, what to see, why and so what? Way forward. Include checklists for PPs, PHIs, DRTBCs,
Need, what to see, why and so what? Way forward.
Discuss the significance of this report. Describe the report from both sides. What are the crucial informations to be captured. What is the importance of each? Source of data. Who will report to whom?
Explain the PMDT review mechanism at various levels, crucial indicators to review, and different committees taking the onus of review.